One to one practical, emotional and confidential staff support to listen and address your specific concerns and/or questions
Group Support – at times, various staff from one ward/department may be cited
Q & A sessions covering expectations of witness
Working in collaboration with external agencies such as Witness Service, Victim Information and Advice (VIA), NMC enabling a dedicated staff centred approach for NHS witnesses
Court Familiarisation visit in advance of trial (subject to COVID restrictions)
Support in court on day of giving your evidence (subject to COVID restrictions)
A dedicated point of support and guidance to you throughout the legal process aiding in your preparation and familiarisation of court and legal process.
Practical information around court processes and expectation of witnesses
Please read over the appropriate pages linked to the side relating to the type of case you are cited to attend. If further support is required, please get in touch with Rachel McGowan or your appropriate Legal Claims Manager for your area if matters relate to a legal claim against the Board.
The Witness Support and Corporate Legal Manager is based at West Glasgow ACH.
Please note: Witness Support is not coaching, influencing or tactical support and advice for attending Court. Witness Support offers reassurance for NHS staff who have been cited to attend Court.
The following videos highlight the support available to NHSGGC staff around Fatal Accident Inquiries (FAI) and Sudden and Unexpected Death Investigations (SUD)
Privacy Notice
As part of our requirements under Data Protection legislation, we have published a Staff Privacy Notice. By issuing this privacy notice, we demonstrate our commitment to openness and accountability.
We recognise the need to treat staff’s personal and sensitive data in a fair and lawful manner. No personal information held by us will be processed unless the requirements for fair and lawful processing can be met.
Contact Information
Rachel McGowan, Witness Support and Corporate Legal Manager based at West Glasgow ACH. Working as a Witness Support and Corporate Legal Manager involves me working closely with a wide variety of clinical and non-clinical staff across the organisation in relation to various legal cases on behalf of the Board.
If you have been asked to attend a Scottish Hospitals Inquiry oral hearing, this short video will provide you with an overview of the hearing room before you arrive.
Open to applicants with SCQF level 10 Qualifications in any discipline, this three year programme with placements in Health Boards across Scotland will give you real management responsibilities, and the chance to work with senior leaders and managers. You will be fully funded to compete a Masters (General Management) or a CIPFA professional qualification (Finance Management).
The Clinical Scientist Training Programme is a three year training programme commissioned by NHS Education Scotland (NES). The programme recruits Life Sciences and Physics/Engineering graduates (minimum 2:1) who wish to train as Clinical Scientists.
The programme includes includes various work-based rotations in hospitals and you will also complete a part-time master’s degree at one of the universities which are part of the programme. During the training you will be paid a salary equivalent to Band 6 on the NHS pay scale (approx. £25000 pa).
Recruitment generally starts in January with a clearly defined deadline.
The Glasgow Centre for Inclusive Living (GCIL) is a user-led organisation, run by disabled people for disabled people. In partnership with organisations including NHS Scotland , the Professional Careers Programme is a 2-year salaried programme hosting placements for graduates on the programme. You will have a professional-level role and could work in any of the NHS Scotland Boards.
Graduate Career Advantage Service (GCAS) is a new initiative which supports recent, eligible graduates living in Scotland to find rewarding employment. we are delighted to be supporting a new NHS Scotland programme of Graduate Internships in partnership with GCAS.
As part of the Scottish Government’s Young Person’s Guarantee, this programme aims to bridge the gap between employers and talented graduates; helping to ease the transition into valuable work experience.
The course will be held over Zoom, and directed at trainees who have passed the Part I exam, and are preparing to sit their Part II exam in March 2026. The virtual course will be based on exam topics and endeavour to reproduce the spirit of previous courses, whilst taking advantage of the strengths of virtual platforms.
The course fee is £900
When the course is fully subscribed, a waiting list will be held from which, trainees will be offered cancellations/withdrawal.
For information or advice regarding the content of this toolkit, quality assurance process or amendments to resources please contact the SMT working group at:
If you are concerned that a young person requires support with alcohol or substance issues, please follow your organisation’s own policies and procedures and discuss with senior management.
There may be additional local support services available within your area. Please contact substance misuse working group for more information if you are unaware of these.
If you are concerned that a young person requires support with alcohol or substance issues, you should direct them towards an appropriate service.
It is better to contact services now to clarify their referral criteria and procedures, rather than waiting until a young person urgently needs their help!
The Greater Glasgow and Clyde Substance Misuse Education Working Group consists of NHS and Education staff who have worked together to create the ‘Substance Misuse Toolkit’. This online resource contains quality assured substance misuse education resources to support staff working with young people in both education and community settings. Resources include lesson plans, resource packs and relevant websites.
The Substance Misuse Toolkit aims to reduce harm caused by substance misuse by:
Equipping staff with the knowledge and confidence they require to teach pupils about the effects, risks and consequences of substance use by providing them with a range of materials and methodologies.
Encouraging learners to make informed choices about alcohol, drugs and tobacco.
Supporting an age appropriate and inclusive approach to education in relation to substances within the context of a Curriculum for Excellence.
Identifying evidence based resources and approaches and share good practice with staff across the Greater Glasgow and Clyde area.
Ensuring that resources are up to date and fit for purpose.
Ensuring ongoing quality assurance processes are in place to monitor and further develop the site.
Quality Assurance
The Greater Glasgow and Clyde Substance Misuse Education Working Group meets regularly to ensure that resources included within the Substance Misuse Toolkit are evidence based, up to date and of a high standard. The group consults with key stakeholders regarding the accessibility, content, usefulness and areas for improvement.
The Greater Glasgow and Clyde Substance Misuse Education Working Group has developed a quality assurance tool to assess the content of resources against agreed indicators. The tool is consistent with the principles and values of local and national policy including Curriculum for Excellence, GIRFEC and the Greater Glasgow and Clyde Alcohol and Drug Prevention and Education Model. Resources which meet the standards set by this review process are then incorporated into the Substance Misuse Toolkit.
The Quality Assurance Tool Template can be accessedhere.
Policy Context
The need to support children and young people to make positive choices about alcohol, drugs and tobacco has been highlighted by a number of national and local policy documents. Substance Misuse Education is a priority within the Greater Glasgow and Clyde Alcohol and Drug Prevention & Education Model and is a Health & Wellbeing organiser within Curriculum for Excellence. Getting it Right for Every Child (GIRFEC) ensures that wellbeing is central to all of our work in meeting children and young people’s needs.
Further information on the policy context can be found here.
Was this helpful?
Yes
No
Thanks for your feedback!
NHS Research Scotland definition
Research Governance concerns setting standards to improve research quality and safeguard the public. It involves enhancing ethical and scientific quality, promoting good practice, reducing adverse incidents, ensuring lessons are learned and preventing poor performance and misconduct.
A broad range of regulations, principles and standards of good practice exist to achieve, and continuously improve, research quality across all aspects of healthcare in the UK and worldwide.
Research governance applies to everyone connected to healthcare research including Chief investigators, health care professionals, researchers, and support staff.
Introduction
Research Governance is essential for the conduct of research on humans and encompasses regulations, good practices, and world- wide collaboration to create an environment ensuring safety of the participants while conducting the studies and trials and the collection and analysis of data to quality standards.
The Research Governance team at NHS Greater Glasgow and Clyde is a support department to researchers and teams and is made up a range of highly qualified individuals such as PhD level scientists with research and Industrial experience, an engineer, auditors and monitors with key skills in QA, clinical trials, Industry, medical devices, drug development, Intellectual property and safety.
The team provide Sponsor support starting from the grant stage of a study, to protocol development, to assessing vendors, to identifying and managing risk and overseeing the conduct of the study, to managing non-compliances, protocol deviations and serious breaches of GCP. This activity covers hundreds of sites across the UK and internationally as NHS GG&C and Glasgow University researchers lead on worldwide research.
The QA team carry out GCP audits, a requirement of the Clinical Trial Regulations, engage with third parties to audit our own activities and provide a Quality system for the production and maintenance of SOPS incorporating all of the departments involved in research e.g. Imaging, safehaven, Bio repository.
The team activity is inspected by the MHRA during Regulatory Sponsor inspections. The Governance manager is a lead for these inspections involving all departments and other organisations. Together with the QA manager they manage the outcomes of inspections and ensure that the findings are addressed.
The Team are also responsible for the oversight of other studies such as surgical, medical devices and hosted studies including commercial and other academic led studies. Due to limited resources this is managed by assessing risk and focusing on areas which may potentially pose safety or quality issues.
During the 2020 COVID-19 pandemic the team led the development and implementation of a process to oversee safety of research participants still taking part in sponsored clinical research led by NHSGGC and its partners.
NHSGGC has already earned a reputation with companies for being open to innovative ideas and partnership working. We aim to build on this. In response to the scale of funding and innovation opportunities that are becoming available, NHSGGC has set up an Innovation Governance Group (IGG). The role of the IGG is to primarily assess consortia and bids that aim to use NHSGGC as an innovation test bed with an aim to;
Prioritise those that align with NHSGGC objectives and strategic delivery plans
Position NHSGGC to attract Innovation funding to support strategic developments.
As part of the processes for IGG we are now using a new system for the registration of innovation projects. To register your innovation project please complete the registration form (here) and send to innovation@ggc.scot.nhs.uk
The competition is live, with registration closing on the 23rd September 1100am and the competition closing on the 30th September 1100am
This is a Small Business Research Initiative (SBRI) competition funded by NHS Scotland. Successful applicants receive 100% funding and access to advice from NHS Highland, NHS Lothian and NHS Greater Glasgow and Clyde.
The overall programme will be delivered in up to 2 phases. This is phase 1. A decision to proceed with phase 2 will depend on the outcomes from phase 1. Only successful applicants from phase 1 will be able to apply to take part in phase 2.
NHS Scotland is investing up to £300,000 including VAT, in innovative solutions in 3 challenge areas as follows:
Challenge A
Using artificial intelligence and machine learning to help develop prediction algorithms and risk stratification for diabetes foot ulceration, amputations and mortality.
Challenge B
Improving the clinical care of patients with a pre-existing diagnosis of diabetes when admitted to hospital by developing a real-time decision support tool and alert mechanism. The tool must improve triage, prevent medication errors, identify emergencies and streamline the diabetes care pathway.
Challenge C
Improving the identification (case finding) of people at risk of osteoporosis and fracture, including those with diabetes.
NHSGG&C RESEARCH ENDOWMENT FUND ALLOCATION 2025/26
NHSGG&C-wide Research Endowment Fund will no longer be hospital specific but will otherwise be awarded in agreement with the terms of the original bequests.
The following categories are open for applications:
Cancer (Funds available – £63,000) Chest, Heart and Stroke (Funds available – £74,000)
General (Funds available – £88,000) Renal (Funds available – £27,000)
The usual amount of funding awarded for each project is in the region of £20k to support specific projects running for a duration of 1 or 2 years. However, exceptional projects are eligible to apply for the full funding available in each funding pot. Priority will be given to projects that demonstrate a clear benefit to the NHS and their Patients.
Endowment funds are specifically intended to support early stage researchers to establish their own research portfolio and attract eligible grants for future studies. Experienced researchers (e.g. 7 years post Consultant or Research team leads) should seek funding for their projects from an alternative source
Completed word document applications must be submitted to R&I for review and sign off by finance no later than the 24th of October 2025. Please send these to Islay Morrison (islay.morrison2@nhs.scot)
Following agreement of costings with finance, fully completed and signed off application forms can be submitted. (1 ELECTRONIC COPY & CV).
Electronic signatures will be accepted. Please submit in word document format.
Submission Deadlines
Submission deadline for project to be costed by finance Friday 24th October
Deadline for project costs to be finalised with R&I finance team – Friday 7th November
Endowment Award Meeting anticipated to take place week commencing Monday 12th January
Applications received after this date will not be accepted
Email completed applications to islay.morrison2@nhs.scot>
CSO are delighted to announce that applications are now open for the next round of CSO Response Mode Research Grants. The deadline for submitting the outline application is Friday 27th June 2025.
We would like to highlight that CSO have implemented a new grants management system.Applicants will be able to submit and manage their applications through all the pre-stage and post award stages through this portal.
Deadline for submission of applications: Friday 15 August 2025 for 19 August 2025 meeting.
Accordion title 1
This is a placeholder tab content. It is important to have the necessary information in the block, but at this stage, it is just a placeholder to help you visualise how the content is displayed. Feel free to edit this with your actual content.
Accordion title 2
This is a placeholder tab content. It is important to have the necessary information in the block, but at this stage, it is just a placeholder to help you visualise how the content is displayed. Feel free to edit this with your actual content.
Form 21.004A – Sponsor IMP Management Risk Assessment Process: Permanent Storage of IMP External to Pharmacy
Form 21.004B – IMP Storage Assessment – Permanent Storage of IMP External to Pharmacy
Guideline 21.004A – Permanent Storage of IMPs External to Pharmacy: Guidance on Risk Mitigation Strategies
SOP 21.005 – Managing Drug Alerts and Other Urgent Defective Medicine Reports for IMPs and NIMPs in Clinical Trials Sponsored or Co-Sponsored by NHS GG&C
SOP 21.011 – Management of temperature deviations and defects in IMPs and NIMPs supplied by Sponsor for clinical trials sponsored or co-sponsored by NHSGGC
Form 21.023A – IVRS/IWRS Specification for Drug Supply Management System(s)
Form 21.023B – IXRS Drug Supply Management Acceptance Testing Approval & Training
Form 21.023C – IXRS User Acceptance Testing Tracker
SOP 21.024 – Management of shelf-life extension for IMPs for research Sponsored by NHSGGC or Co-Sponsored by NHSGGC & UoG or when NHSGGC are UK Lead or Coordinating Centre for another Sponsor
Guideline 21.024A – Detailed guidance on IMP date extension process for research Sponsored by NHSGGC or Co-Sponsored by NHSGGC & UoG or when NHSGGC are UK Lead or Coordinating Centre for another Sponsor
SOP 21.025 – Management of Dose Escalation in Early Phase IMP/ATIMP Clinical Trials
Guideline 22.008E – Process for configuring data loggers for mapping and commissioning of refrigerators and freezers and monitoring temperatures external to pharmacy
SOP 22.009 – Dispensing and accuracy checking for clinical trial supplies
Form 51.007D – Responsibilities delegated to the Chief Investigator for CTIMP Trials Co-Sponsored by the University of Glasgow and NHS GG&C
Form 51.007E – Responsibilities delegated to the Chief Investigator for CTIMP Trials Sponsored by NHS GG&C
SOP 51.008 – Handling Non-Compliance with Good Clinical Practice (GCP) and/or the trial protocol in clinical research Sponsored, Co-Sponsored or Hosted by NHS Greater Glasgow and Clyde
Guideline 51.008C – Guidance on Types of Non-Compliance and Associated Documentation
SOP 51.009 – Notification of Serious Breaches of Good Clinical Practice or the Trial Protocol for Clinical Trials of Investigational Medicinal Products and non-CA marked Medical Devices
Form 51.028A – Categorising Laboratory Tests undertaken within Research Projects Sponsored by NHS GG&C or Co-Sponsored by NHS GG&C and University of Glasgow
SOP 51.029 – Writing Study Specific Laboratory Manuals for Research Sponsored by NHSGGC or Co-Sponsored by NHSGGC and the University of Glasgow
SOP 51.030 – Writing Sample Handling Manuals for Sites Participating in Research Sponsored by NHSGGC or Co-Sponsored by NHSGGC and the University of Glasgow
SOP 51.033 – Research Imaging for Trials involving an Investigative Medicinal Compound (CTIMP) Sponsored by NHS GG&C or Co-sponsored by NHS GG&C and the University of Glasgow (UoG)
SOP 51.034 – Writing a Trial Specific Research Imaging Manual for Sites Participating in CTIMP Sponsored by NHS GG&C or Co-sponsored by NHS GG&C and University of Glasgow (UoG)
SOP 51.036 – Trial Steering Committee for Trials involving an Investigative Medicinal Product (CTIMP) Sponsored by NHSGGC or Co-Sponsored by NHSGGC and the University of Glasgow
Form 51.036A – Letter of Invitation to TSC member NHSGGC sole Sponsor
Form 51.036B – Letter of Invitation to TSC member NHSGGC/UoG Co-Sponsor
SOP 51.037 – Storage and Transfer of Laboratory Data for Clinical Trials and Investigations Sponsored by NHS Greater Glasgow & Clyde (NHS GG&C) or Co-Sponsored by NHS GG&C & University of Glasgow
Guideline 55.002A – PV Office Creation and submission of Development Safety Update Reports
SOP 55.004 – Safety RepSafety Reporting Requirements for Research Other Than Clinical Trials of Investigational Medicinal Products and non CE Marked Medical Devices
Guideline 55.006A – Summary of Product Characteristics (SmPC) & Investigator s Brochure Checks
SOP 55.007 – Safety Reporting in Clinical Trials of Medical Devices of Non CE Marked Medical Devices or CE Marked Devices Used Outside of their Intended Purpose (Sponsored and Hosted Clinical Investigations)
We use cookies to analyse traffic to our site and to enable certain functions such as forms and YouTube videos. These do not collect personal information. By clicking "Accept All", you consent to our use of cookies, or you can customise the options.
This website uses cookies
Websites store cookies to enhance functionality and personalise your experience. You can manage your preferences, but blocking some cookies may impact site performance and services.
Essential cookies enable basic functions and are necessary for the proper function of the website.
Name
Description
Duration
Cookie Preferences
This cookie is used to store the user's cookie consent preferences.
30 days
CloudFlare provides web performance and security solutions, enhancing site speed and protecting against threats.
Sequence rules uses cookies to track the order of requests a user has made and the time between requests and makes them available via Cloudflare Rules. This allows you to write rules that match valid or invalid sequences. The specific cookies used to validate sequences are called sequence cookies.
session
cf_ob_info
The cf_ob_info cookie provides information on: The HTTP Status Code returned by the origin web server. The Ray ID of the original failed request. The data center serving the traffic
session
cf_chl_rc_m
These cookies are for internal use which allows Cloudflare to identify production issues on clients.
session
__cfruid
Used by the content network, Cloudflare, to identify trusted web traffic.
session
__cf_bm
Cloudflare's bot products identify and mitigate automated traffic to protect your site from bad bots. Cloudflare places the __cf_bm cookie on End User devices that access Customer sites that are protected by Bot Management or Bot Fight Mode. The __cf_bm cookie is necessary for the proper functioning of these bot solutions.
session
__cflb
When enabling session affinity with Cloudflare Load Balancer, Cloudflare sets a __cflb cookie with a unique value on the first response to the requesting client. Cloudflare routes future requests to the same origin, optimizing network resource usage. In the event of a failover, Cloudflare sets a new __cflb cookie to direct future requests to the failover pool.
session
_cfuvid
The _cfuvid cookie is only set when a site uses this option in a Rate Limiting Rule, and is only used to allow the Cloudflare WAF to distinguish individual users who share the same IP address.
session
cf_clearance
Whether a CAPTCHA or Javascript challenge has been solved.
session
cf_use_ob
The cf_use_ob cookie informs Cloudflare to fetch the requested resource from the Always Online cache on the designated port. Applicable values are: 0, 80, and 443. The cf_ob_info and cf_use_ob cookies are persistent cookies that expire after 30 seconds.
session
__cfwaitingroom
The __cfwaitingroom cookie is only used to track visitors that access a waiting room enabled host and path combination for a zone. Visitors using a browser that does not accept cookies cannot visit the host and path combination while the waiting room is active.
session
cf_chl_rc_i
These cookies are for internal use which allows Cloudflare to identify production issues on clients.
session
cf_chl_rc_ni
These cookies are for internal use which allows Cloudflare to identify production issues on clients.
